Research ArticleArticle
Clinical Features of Patients with Morphea and the Pansclerotic Subtype: A Cross-sectional Study from the Morphea in Adults and Children Cohort
Andrew Kim, Nicholas Marinkovich, Rebecca Vasquez and Heidi T. Jacobe
The Journal of Rheumatology December 2013, jrheum.130029; DOI: https://doi.org/10.3899/jrheum.130029
Andrew Kim
From the Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Dermatology, Washington Hospital Center, Washington, DC, USA. Research for this manuscript was supported in part by US National Institutes of Health (NIH) Grant No. K23AR056303-4. Also supported in part by the UT-STAR, NIH/NCRR/NCATS Grant No. UL1RR024982. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and healthcare centers, the National Center for Research Resources, or the NIH. A. Kim, MD, Department of Dermatology, University of Texas Southwestern Medical Center; N. Marinkovich, MD, Department of Dermatology, Washington Hospital Center; R. Vasquez, MD; H.T. Jacobe, MD, MSCS, Department of Dermatology, University of Texas Southwestern Medical Center. Address correspondence to Dr. H.T. Jacobe, University of Texas Southwestern Medical Center, Department of Dermatology, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9069, USA. E-mail: heidi.jacobe@utsouthwestern.edu. Accepted for publication August 8, 2013.
Nicholas Marinkovich
From the Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Dermatology, Washington Hospital Center, Washington, DC, USA. Research for this manuscript was supported in part by US National Institutes of Health (NIH) Grant No. K23AR056303-4. Also supported in part by the UT-STAR, NIH/NCRR/NCATS Grant No. UL1RR024982. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and healthcare centers, the National Center for Research Resources, or the NIH. A. Kim, MD, Department of Dermatology, University of Texas Southwestern Medical Center; N. Marinkovich, MD, Department of Dermatology, Washington Hospital Center; R. Vasquez, MD; H.T. Jacobe, MD, MSCS, Department of Dermatology, University of Texas Southwestern Medical Center. Address correspondence to Dr. H.T. Jacobe, University of Texas Southwestern Medical Center, Department of Dermatology, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9069, USA. E-mail: heidi.jacobe@utsouthwestern.edu. Accepted for publication August 8, 2013.
Rebecca Vasquez
From the Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Dermatology, Washington Hospital Center, Washington, DC, USA. Research for this manuscript was supported in part by US National Institutes of Health (NIH) Grant No. K23AR056303-4. Also supported in part by the UT-STAR, NIH/NCRR/NCATS Grant No. UL1RR024982. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and healthcare centers, the National Center for Research Resources, or the NIH. A. Kim, MD, Department of Dermatology, University of Texas Southwestern Medical Center; N. Marinkovich, MD, Department of Dermatology, Washington Hospital Center; R. Vasquez, MD; H.T. Jacobe, MD, MSCS, Department of Dermatology, University of Texas Southwestern Medical Center. Address correspondence to Dr. H.T. Jacobe, University of Texas Southwestern Medical Center, Department of Dermatology, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9069, USA. E-mail: heidi.jacobe@utsouthwestern.edu. Accepted for publication August 8, 2013.
Heidi T. Jacobe
From the Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Dermatology, Washington Hospital Center, Washington, DC, USA. Research for this manuscript was supported in part by US National Institutes of Health (NIH) Grant No. K23AR056303-4. Also supported in part by the UT-STAR, NIH/NCRR/NCATS Grant No. UL1RR024982. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and healthcare centers, the National Center for Research Resources, or the NIH. A. Kim, MD, Department of Dermatology, University of Texas Southwestern Medical Center; N. Marinkovich, MD, Department of Dermatology, Washington Hospital Center; R. Vasquez, MD; H.T. Jacobe, MD, MSCS, Department of Dermatology, University of Texas Southwestern Medical Center. Address correspondence to Dr. H.T. Jacobe, University of Texas Southwestern Medical Center, Department of Dermatology, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9069, USA. E-mail: heidi.jacobe@utsouthwestern.edu. Accepted for publication August 8, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Clinical Features of Patients with Morphea and the Pansclerotic Subtype: A Cross-sectional Study from the Morphea in Adults and Children Cohort
Andrew Kim, Nicholas Marinkovich, Rebecca Vasquez, Heidi T. Jacobe
The Journal of Rheumatology Dec 2013, jrheum.130029; DOI: 10.3899/jrheum.130029